Answers are grounded in this paper and cite their sources.
We report the emergence of non-susceptibility to cefiderocol from a subpopulation of Pseudomonas aeruginosa recovered from a patient without history of cefiderocol exposure. Whole genome sequencing identified mutations in major iron transport pathways previously associated with cefiderocol uptake. Susceptibility testing should be performed before therapy with siderophore cephalosporins.
No takes yet. Share an insight, caveat, or question.
Streling et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: